Jianmin Pharmaceutical Group Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001HB7
CNY
32.61
0.1 (0.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,351.41
3,482.69
4,184.12
3,620.34
3,259.14
2,442.96
2,223.02
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,351.41
3,482.69
4,184.12
3,620.34
3,259.14
2,442.96
2,223.02
Raw Material Cost
1,445.11
1,871.02
2,302.64
2,092.61
1,873.26
1,478.25
1,360.93
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.32
14.01
4.82
5.60
3.71
0.96
0.97
Selling and Distribution Expenses
1,580.97
1,434.93
1,502.02
1,212.31
1,113.04
876.03
780.11
Other Expenses
7.66
5.79
6.44
6.06
4.51
3.31
3.62
Total Expenditure (Excl Depreciation)
3,116.96
3,377.91
3,873.89
3,371.16
3,035.14
2,388.32
2,178.17
Operating Profit (PBDIT) excl Other Income
234.4
104.80000000000001
310.2
249.20000000000002
224
54.6
44.900000000000006
Other Income
47.36
42.73
72.20
70.08
34.62
14.03
9.53
Operating Profit (PBDIT)
349.85
223.29
443.93
369.79
294.51
97.17
77.67
Interest
14.32
14.01
4.82
5.60
3.71
0.96
0.97
Exceptional Items
16.69
27.89
5.83
-21.95
-2.55
-2.99
-3.72
Gross Profit (PBDT)
1,906.30
1,611.67
1,881.48
1,527.73
1,385.88
964.71
862.09
Depreciation
71.84
70.58
59.06
54.68
39.78
30.59
25.76
Profit Before Tax
280.37
166.59
385.89
287.56
248.47
62.64
47.23
Tax
25.84
24.87
47.86
32.44
35.51
8.92
7.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
359.84
362.18
521.46
407.57
324.74
147.79
91.49
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
359.84
362.18
521.46
407.57
324.74
147.79
91.49
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
5.38
5.57
1.78
-2.07
0.68
0.90
1.14
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
365.22
367.75
523.23
405.50
325.42
148.69
92.63
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,656.39
2,435.31
2,247.71
1,862.86
1,561.21
1,316.91
1,201.46
Earnings per share (EPS)
2.35
2.36
3.41
2.68
2.13
0.96
0.6
Diluted Earnings per share
2.35
2.36
3.41
2.68
2.13
0.96
0.6
Operating Profit Margin (Excl OI)
6.88%
3.16%
7.47%
6.77%
6.75%
2.15%
1.91%
Gross Profit Margin
10.51%
6.81%
10.63%
9.45%
8.84%
3.82%
3.28%
PAT Margin
10.74%
10.4%
12.46%
11.26%
9.96%
6.05%
4.12%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -3.77% vs -16.76% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -0.68% vs -29.72% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 67.50% vs -51.41% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 2.14% vs 191.67% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Jianmin Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
3,351.41
0
3,351.41
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,351.41
0
3,351.41
Raw Material Cost
1,445.11
0
1,445.11
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
14.32
0
14.32
Selling and Distribution Expenses
1,580.97
0
1,580.97
Other Expenses
7.66
0.00
7.66
Total Expenditure (Excl Depreciation)
3,116.96
0
3,116.96
Operating Profit (PBDIT) excl Other Income
234.45
0.00
234.45
Other Income
47.36
0
47.36
Operating Profit (PBDIT)
349.85
0
349.85
Interest
14.32
0
14.32
Exceptional Items
16.69
0
16.69
Gross Profit (PBDT)
1,906.30
0
1,906.30
Depreciation
71.84
0
71.84
Profit Before Tax
280.37
0
280.37
Tax
25.84
0
25.84
Provisions and contingencies
0
0
0.00
Profit After Tax
359.84
0
359.84
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
359.84
0
359.84
Share in Profit of Associates
0
0
0.00
Minority Interest
5.38
0
5.38
Other related items
0.00
0.00
0.00
Consolidated Net Profit
365.22
0
365.22
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,656.39
0
2,656.39
Earnings per share (EPS)
2.35
0
2.35
Diluted Earnings per share
2.35
0
2.35
Operating Profit Margin (Excl OI)
6.88%
0%
0.00
6.88%
Gross Profit Margin
10.51%
0%
0.00
10.51%
PAT Margin
10.74%
0%
0.00
10.74%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 335.14 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -3.77% vs -16.76% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 36.52 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -0.68% vs -29.72% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 30.25 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 67.50% vs -51.41% in Dec 2024

Annual - Interest
Interest 1.43 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 2.14% vs 191.67% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.88%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024